CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent

NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 05, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today notes the announcement issued by Sarborg Limited (“Sarborg”) ...
TMCnet

Keys Inc. Files U.S. Provisional Patent Application for Autonomous AI Infrastructure Redefining On-Demand Service Networks

TUCSON, Ariz., March 2, 2026 /PRNewswire/ -- Keys Inc. today announced the filing of U.S. Provisional Patent Application No.
JD Supra

Avoiding the Provisional Application Filing Pitfall of Narrowed Claim Interpretation

Provisional patent applications are popular in the U.S. for the various advantages they may provide applicants, including lower filing costs, less restrictive United States Patent and Trademark Office ...
Nasdaq

Raphael Pharmaceutical Announces Filing of Provisional Patent Application for the Treatment of Neutrophil-Dominant Autoimmune Diseases, Including Rheumatoid Arthritis (RA)

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (“Raphael Pharmaceutical” or the “Company”) (OTCQB: RAPH), a clinical-stage biotechnology company developing an innovative ...
JD Supra

Nutter Patent Basics, Part 1: What Happens After a Patent Application Is Filed in the U.S.?

Part 1 in our series details the process of turning a patent application into a granted patent in the United States, and Part 2 will outline the process of obtaining patent protection in other ...
Morningstar

LegalZoom Launches Streamlined Provisional Patent Filing Product to Help Businesses and Entrepreneurs Protect Intellectual Property, Secure Funding and Drive Growth

LegalZoom Launches Streamlined Provisional Patent Filing Product to Help Businesses and Entrepreneurs Protect Intellectual Property, Secure Funding and Drive Growth LegalZoom’s law firm to provide ...
IPWatchdog

Can You Refile a Provisional Patent Application?

“Refiling a provisional is just a bad idea when you can, for a few hundred dollars more, keep hold of that earliest priority date and continue on the path to obtaining a patent.” The question that we ...
Seeking Alpha

Raphael Pharmaceutical Announces Filing of Provisional Patent Application for the Treatment of Neutrophil-Dominant Autoimmune Diseases, Including Rheumatoid Arthritis (RA)

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (RAPH), a clinical-stage biotechnology company developing an innovative research platform based on cannabinoids free of THC and ...